The Nutraceuticals Market Is Expected To Grow To $275 Billion By 2021

UNITED KINGDOM:  Humans have been consuming choice foods for their medical benefits for millennia. The ancient Egyptians had over 800 known pharmacological treatments for disease, of which 160 were plant products – including compounds being investigated for use in disease today, such as cannabis Historically, herbal medicine utilized many compounds that are now considered nutraceuticals. For instance, bitter apple, Citrullus colocynthis, is described in ancient medical texts, and has been shown to have positive efficacy in clinical trials for uses in cancer and diabetes.

Nutraceuticals market is growing and diversifying rapidly. These products are linked by the fact that they are dietary products that have some degree of either purported or clinically evidenced medical benefit. However, the market lacks a clear definition of what constitutes a nutraceutical, with the term covering a spectrum of products from prescription-only medical foods to widely available consumer supplements.

KPMG forecast that the nutraceuticals market will be worth around $250 billion by 2018, and while the exact scope of what is considered a nutraceutical is broad and variable, the products identified in the KPMG report largely fell within the GBI definition of nutraceuticals. The value of the nutraceuticals industry is over 25% of the value of the pharmaceutical industry, and under 5% of the value of the food industry. Analysts have predicted about 7.3% compound annual growth rate (CAGR) for nutraceuticals from 2015 to 2021, with the market expected to be worth over $275 billion by 2021. This compares favorably with the CAGR of around 4% witnessed from 2002 to 2010.

The report “Nutraceuticals: New Applications for Probiotics, Genetic Modification and Diet as Products Make Gains in Rx Territory” provides key industry perspective on the nutraceuticals industry from a large survey of over 150 food and pharmaceutical industry professionals, both within and outside of the nutraceuticals sector. Those involved in the industry were found to mostly believe in the value propositions of nutraceuticals, and expected their company to increase its level of investment in the area. In contrast, for those not involved with nutraceuticals the opposite was generally true.

Scope
– How can the nutraceuticals sector be defined in general, and what types of product does it include?
– What are the key strategies used in marketing and developing some of the leading nutraceutical products?
– What are the key companies involved in nutraceuticals?
– What are some of the key upcoming products, companies and research trends within nutraceuticals?
– How does the regulatory landscape for different types of nutraceutical vary in key territories?
– What factors have hindered the growth of the nutraceuticals market?
– How can companies grow successfully within the nutraceuticals market?

Reasons to buy
– Understand the complex differences in the regional regulation of nutraceuticals, and how they shape the market
– Understand key future trends in the nutraceuticals market
– Gain an understanding of the industry perspective on critical aspects of the nutraceuticals industry, such as drivers, barriers, promising geographies and the value propositions of products
– Understand the strategies of key players from the food and pharmaceutical industries that are involved in the nutraceuticals market

Download the full report. 

Legal Cannabis Market Gains Popularity

NEW YORK:  The cannabis market is growing rapidly in North American. According to a report from Market Research Future, the North American market size of cannabis is expected to expand at a CAGR over 33% over the period of 2016 to 2021. The report indicates that the U.S., Canada and Mexico are the major markets for cannabis, while the U.S. is the largest one, accounted for 95% of the market size of the North America cannabis market. Canada market is also expected to experience fast growth as the federal government may announce plans to make cannabis legal for recreational use across the entire country in the spring.

The report also indicated the factors that drive the growth: “Rapid legalizing and growing awareness about the medicinal properties of marijuana to boost the market over the forecasted period…Among the country markets in North America, The U.S. and Canada accumulate significant revenue, owing to rapid legalization in the country, increasing number of evidences in favor of marijuana possessing medicinal properties, and growing acceptance among end-users”

Marijuana Initiatives Will Add $7.4 Billion To Market

CALIFORNIA:  Arcview Market Research, in partnership with New Frontier Data, have released a special election update to the official Arcview Market Research growth projections in light of victories from 8 of the 9 marijuana ballot initiatives. The passage of initiatives in California, Nevada, Massachusetts, Maine, Florida, Arkansas, Montana, and North Dakota will add $7.4 billion to the 2020 market forecast bringing the overall market projection for legal adult-use and medical sales in the U.S. to $21.2 billion by 2020. That brings the compound annual growth rate (CAGR) to 28%.

“There is nothing more powerful than an idea whose time has come. This is marijuana’s moment,” said Arcview Group CEO, Troy Dayton. “Even without these initiatives passing, the legal marijuana market was poised for remarkable growth. Now, with these legalization victories, growth will be off the charts. You will not find another multi-billion dollar industry growing at this rate that isn’t already attracting huge multi-national companies and institutional investors. It’s truly a historic opportunity for pioneering investors and entrepreneurs to take a run at a huge market without needing to compete with the really big dogs…yet.”

“Recent polls have shown 60 percent of the public supports adult use legalization. Nine in ten support the legalization of medical use. The ten initiatives on the ballot reflect the accelerating public debated on legal cannabis access. The passage of these measures shows that public support on this issue is not solely confined to urban, liberal markets but extends into conservative rural states as well,” said Giadha DeCarcer, Founder and CEO of New Frontier.

Below are the 2020 Arcview Market Research projections for various state markets that passed initiatives (presuming new markets are operational by 2018):

California: Medical — $3.3B, Adult Use — $4.3B, Total Market = $7.6B

Maine: Medical — $129M, Adult Use — $196M, Total Market = $325M

Massachusetts: Medical — $301M, Adult Use — $771M, Total Market = $1.1B

Nevada: Medical — $193M, Adult Use — $429M, Total Market = $622M

Arkansas: Total Medical Market = $6.4M

Florida: Total Medical Market = $1.6B

Montana: Total Medical Market = $128M

North Dakota: $2.3M

For a deep dive into the market dynamics in each state and trends driving this market please download a copy of the 4th edition of the State of Legal Marijuana Markets. The report is downloadable at www.ArcviewMarketResearch.com and www.frontierfinancials.com.